Induced pluripotent stem cells and their use in human models of disease and development

P Karagiannis, K Takahashi, M Saito… - Physiological …, 2019 - journals.physiology.org
The discovery of somatic cell nuclear transfer proved that somatic cells can carry the same
genetic code as the zygote, and that activating parts of this code are sufficient to reprogram …

Exploring the promising potential of induced pluripotent stem cells in cancer research and therapy

M Chehelgerdi, F Behdarvand Dehkordi… - Molecular Cancer, 2023 - Springer
The advent of iPSCs has brought about a significant transformation in stem cell research,
opening up promising avenues for advancing cancer treatment. The formation of cancer is a …

How I treat juvenile myelomonocytic leukemia

F Locatelli, CM Niemeyer - Blood, The Journal of the American …, 2015 - ashpublications.org
Juvenile myelomonocytic leukemia (JMML) is a unique, aggressive hematopoietic disorder
of infancy/early childhood caused by excessive proliferation of cells of monocytic and …

Juvenile myelomonocytic leukemia: who's the driver at the wheel?

CM Niemeyer, C Flotho - Blood, The Journal of the American …, 2019 - ashpublications.org
Juvenile myelomonocytic leukemia (JMML) is a unique clonal hematopoietic disorder of
early childhood. It is classified as an overlap myeloproliferative/myelodysplastic neoplasm …

The use of stem cell-derived organoids in disease modeling: an update

J Azar, HF Bahmad, D Daher, MM Moubarak… - International Journal of …, 2021 - mdpi.com
Organoids represent one of the most important advancements in the field of stem cells
during the past decade. They are three-dimensional in vitro culturing models that originate …

Patient-derived induced pluripotent stem cells in cancer research and precision oncology

EP Papapetrou - Nature medicine, 2016 - nature.com
Together with recent advances in the processing and culture of human tissue,
bioengineering, xenotransplantation and genome editing, Induced pluripotent stem cells …

Organoid cultures for cancer modeling

HHN Yan, AS Chan, FPL Lai, SY Leung - Cell Stem Cell, 2023 - cell.com
Organoids derived from adult stem cells (ASCs) and pluripotent stem cells (PSCs) are
important preclinical models for studying cancer and developing therapies. Here, we review …

[HTML][HTML] RAS diseases in children

CM Niemeyer - Haematologica, 2014 - ncbi.nlm.nih.gov
RAS genes encode a family of 21 kDa proteins that are an essential hub for a number of
survival, proliferation, differentiation and senescence pathways. Signaling of the RAS …

Progress and prospects in pediatric leukemia

PP Madhusoodhan, WL Carroll, T Bhatla - Current problems in pediatric …, 2016 - Elsevier
Pediatric leukemia is the single most common malignancy affecting children, representing
up to 30% of all pediatric cancers. Dramatic improvements in survival for acute …

hi PSC‐derived iMSC s: NextGen MSC s as an advanced therapeutically active cell resource for regenerative medicine

V Sabapathy, S Kumar - Journal of cellular and molecular …, 2016 - Wiley Online Library
Mesenchymal stem cells (MSC s) are being assessed for ameliorating the severity of graft‐
versus‐host disease, autoimmune conditions, musculoskeletal injuries and cardiovascular …